======= UBASH3B ======= == Gene Information == * **Official Symbol**: UBASH3B * **Official Name**: ubiquitin associated and SH3 domain containing B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84959|84959]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8TF42|Q8TF42]] * **Interactions**: [[https://thebiogrid.org/search.php?search=UBASH3B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20UBASH3B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609201|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Interferes with CBL-mediated down-regulation and degradation of receptor-type tyrosine kinases. Promotes accumulation of activated target receptors, such as T-cell receptors and EGFR, on the cell surface. Exhibits tyrosine phosphatase activity toward several substrates including EGFR, FAK, SYK, and ZAP70. Down-regulates proteins that are dually modified by both protein tyrosine phosphorylation and ubiquitination. {ECO:0000269|PubMed:15159412, ECO:0000269|PubMed:17880946}. |His Phos 1| |collagen-activated tyrosine kinase receptor signaling pathway| |negative regulation of platelet aggregation| |collagen-activated signaling pathway| |negative regulation of bone resorption| |negative regulation of homotypic cell-cell adhesion| |negative regulation of bone remodeling| |regulation of platelet aggregation| |negative regulation of platelet activation| |negative regulation of tissue remodeling| |regulation of homotypic cell-cell adhesion| |negative regulation of osteoclast differentiation| |regulation of platelet activation| |phosphoprotein binding| |regulation of bone resorption| |platelet aggregation| |negative regulation of myeloid leukocyte differentiation| |phosphatase activity| |regulation of bone remodeling| |negative regulation of blood coagulation| |negative regulation of hemostasis| |negative regulation of coagulation| |homotypic cell-cell adhesion| |regulation of osteoclast differentiation| |negative regulation of wound healing| |regulation of tissue remodeling| |negative regulation of myeloid cell differentiation| |regulation of release of sequestered calcium ion into cytosol| |regulation of blood coagulation| |regulation of hemostasis| |regulation of coagulation| |negative regulation of response to wounding| |regulation of calcium ion transport into cytosol| |protein tyrosine phosphatase activity| |negative regulation of leukocyte differentiation| |peptidyl-tyrosine dephosphorylation| |regulation of myeloid leukocyte differentiation| |regulation of sequestering of calcium ion| |negative regulation of hemopoiesis| |platelet activation| |regulation of wound healing| |regulation of calcium ion transmembrane transport| |regulation of response to wounding| |negative regulation of cell-cell adhesion| |negative regulation of cell activation| |protein dephosphorylation| |regulation of protein binding| |negative regulation of protein kinase activity| |regulation of myeloid cell differentiation| |negative regulation of kinase activity| |regulation of calcium ion transport| |regulation of leukocyte differentiation| |negative regulation of cell adhesion| |negative regulation of transferase activity| |ubiquitin protein ligase binding| |blood coagulation| |coagulation| |hemostasis| |dephosphorylation| |regulation of cation transmembrane transport| |negative regulation of response to external stimulus| |regulation of binding| |regulation of metal ion transport| |regulation of cell-cell adhesion| |negative regulation of protein phosphorylation| |negative regulation of immune system process| |negative regulation of phosphorylation| |regulation of hemopoiesis| |regulation of ion transmembrane transport| |wound healing| |regulation of body fluid levels| |cell-cell adhesion| |transmembrane receptor protein tyrosine kinase signaling pathway| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |regulation of transmembrane transport| |response to wounding| |negative regulation of protein modification process| |regulation of cell activation| |regulation of cell adhesion| |regulation of ion transport| |negative regulation of cell differentiation| |enzyme linked receptor protein signaling pathway| |negative regulation of catalytic activity| |regulation of protein kinase activity| |regulation of kinase activity| |regulation of cellular localization| |cell adhesion| |biological adhesion| |negative regulation of developmental process| |regulation of transferase activity| |negative regulation of cellular protein metabolic process| |identical protein binding| |cell activation| |regulation of response to external stimulus| |negative regulation of protein metabolic process| |negative regulation of molecular function| |negative regulation of multicellular organismal process| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |regulation of protein phosphorylation| |regulation of response to stress| |regulation of phosphorylation| |negative regulation of response to stimulus| |regulation of immune system process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |regulation of protein modification process| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|-2.09| |[[:results:exp50|Nicotinamide 2000μM R01 exp50]]|-1.75| |[[:results:exp303|39°C R06 exp303]]|-1.72| |[[:results:exp70|INK128 0.2μM R02 exp70]]|1.71| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|1.79| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|2.32| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13888 * **Expression level (log2 read counts)**: 6.52 {{:chemogenomics:nalm6 dist.png?nolink |}}